Vir Biotechnology (NASDAQ:VIR) on Friday announced 24-week post-end-of-treatment data from a mid-stage trial for tobevibart ...

May is Hepatitis Awareness Month, and the Michigan Department of Health and Human Services (MDHHS) is encouraging Michigan ...

Vir Biotechnology’s sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the ...

Pentoxifylline fails to show survival benefits in patients with severe alcohol-associated hepatitis complicated by acute ...

The Coaltion for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, ...

On Hepatitis Testing Day 2025 learn how Hepatitis B differs from jaundice Understand their causes symptoms and treatments and why timely diagnosis is crucial Read on to know more!